US WorldMeds Overview
- Year Founded
-
2001
- Status
-
Private
- Employees
-
190
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
US WorldMeds General Information
Description
Developer of drugs intended to improve the lives of patients with challenging conditions and unmet medical needs. The company's pharmaceuticals are developed mainly for Parkinson's disease, cervical dystonia, malignant hyperthermia, and other rare diseases, enabling physicians to improve the lives of patients suffering from medical problems.
Contact Information
Website
www.usworldmeds.comCorporate Office
- 4441 Springdale Road
- Louisville, KY 40241
- United States
Corporate Office
- 4441 Springdale Road
- Louisville, KY 40241
- United States
US WorldMeds Timeline
US WorldMeds Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 01-Aug-2026 | Completed | Generating Revenue | |||
| 6. Debt - Acquisition | 31-Jul-2025 | Completed | Generating Revenue | |||
| 5. Grant | 30-Sep-2021 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 30-May-2018 | Cancelled | Generating Revenue | |||
| 3. Later Stage VC | 12-Apr-2018 | Completed | Generating Revenue | |||
| 2. Debt - General | 01-Nov-2015 | Completed | Generating Revenue | |||
| 1. Seed Round | 13-Nov-2006 | Completed | Generating Revenue |
US WorldMeds Comparisons
Industry
Financing
Details
US WorldMeds Competitors (9)
One of US WorldMeds’s 9 competitors is CURx Pharmaceuticals, a Corporation company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CURx Pharmaceuticals | Corporation | San Diego, CA | ||||
| Grünenthal | Private Equity-Backed | Aachen, Germany | ||||
| Ethicor Pharma | Corporation | Chester, United Kingdom | ||||
| Vanda Pharmaceuticals | Formerly VC-backed | Washington, DC | ||||
| Agile Therapeutics | Formerly VC-backed | Princeton, NJ |
US WorldMeds Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
US WorldMeds Patents
US WorldMeds Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023177839-A1 | Stable epinephrine macromolecular inclusion complexes, and methods of making and using same | Inactive | 17-Mar-2022 | ||
| AU-2022381070-A1 | Methods of treating patients having type 1 diabetes with eflornithine | Pending | 02-Nov-2021 | ||
| EP-4426429-A1 | Methods of treating patients having type 1 diabetes with eflornithine | Pending | 02-Nov-2021 | ||
| EP-4426429-A4 | Methods of treating patients having type 1 diabetes with eflornithine | Pending | 02-Nov-2021 | ||
| WO-2022169582-A1 | Compositions and methods for clear concentrated parenteral delivery of dantrolene therapeutic agents | Inactive | 05-Feb-2021 | A61K9/19 |
US WorldMeds Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
US WorldMeds Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government |
US WorldMeds Investments & Acquisitions (4)
US WorldMeds’s most recent deal was a Merger/Acquisition with Orbus Therapeutics. The deal was made on 27-Oct-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Orbus Therapeutics | 27-Oct-2026 | Merger/Acquisition | Drug Discovery | ||
| Adaptimmune Therapeutics (TECELRA, lete-cel, afami-cel and uza-cel Cell Therapy Assets) | 27-Jul-2025 | Corporate Asset Purchase | Buildings and Property | ||
| HEMA Biologics | 01-Jan-2016 | Joint Venture | Pharmaceuticals | ||
| Solstice Neurosciences | 06-Aug-2010 | Merger/Acquisition | Pharmaceuticals |
US WorldMeds Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Solstice Neurosciences | Louisville, KY | 2004 |
US WorldMeds FAQs
-
When was US WorldMeds founded?
US WorldMeds was founded in 2001.
-
Where is US WorldMeds headquartered?
US WorldMeds is headquartered in Louisville, KY.
-
What is the size of US WorldMeds?
US WorldMeds has 190 total employees.
-
What industry is US WorldMeds in?
US WorldMeds’s primary industry is Pharmaceuticals.
-
Is US WorldMeds a private or public company?
US WorldMeds is a Private company.
-
What is US WorldMeds’s current revenue?
The current revenue for US WorldMeds is .
-
How much funding has US WorldMeds raised over time?
US WorldMeds has raised $247M.
-
Who are US WorldMeds’s investors?
National Institutes of Health has invested in US WorldMeds.
-
Who are US WorldMeds’s competitors?
CURx Pharmaceuticals, Grünenthal, Ethicor Pharma, Vanda Pharmaceuticals, and Agile Therapeutics are some of the 9 competitors of US WorldMeds.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
